Combined occurrence of diabetes mellitus and retinitis pigmentosa

Annals of Saudi Medicine

Volumn 30, Issue 1, 2010, Pages 70-75

  Al Adsani, Afaf ^a   Gader, Fadl A ^a  

^a AL SABAH HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; ROSIGLITAZONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALSTROM SYNDROME; ARTICLE; ATAXIA; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; BARDET BIEDL SYNDROME; BLINDNESS; BODY MASS; CASE REPORT; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GENE MAPPING; GLYCEMIC CONTROL; HEARING IMPAIRMENT; HEPATOMEGALY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGONADISM; KIDNEY CYST; KIDNEY DISEASE; KIDNEY FAILURE; LIVER BIOPSY; LIVER DISEASE; MALE; NOCICEPTION; NONALCOHOLIC FATTY LIVER; OPTIC NERVE ATROPHY; PERCEPTION DEAFNESS; POLYDACTYLY; PRIORITY JOURNAL; PROTEINURIA; RETINITIS PIGMENTOSA; SENSORY DYSFUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL DISORDER;

ADULT; ALSTROM SYNDROME; ATAXIA; BARDET-BIEDL SYNDROME; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN RESISTANCE; MALE; RETINITIS PIGMENTOSA;

EID: 77249144852     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.59381     Document Type: Article

References (24)

1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368:1795-1809
2. Ross AJ, Beales PL. Bardet-Biedl syndrome [internet]. GeneReviews [cited 2008 December. Available from http://www.geneclinics.org/profiles/all.html.
3. Green JS, Parfrey PS, Harnett JD, Farid NR, Cramer BC, Johnson G, et al. The cardinal manifestations of Bardet-Biedl syndrome: A form of Laurence-Moon-Biedl syndrome. N Eng J Med 1989;321:1002-1009
4. O'Dea D, Parfrey PS, Harnett JD, Hefferton D, Cramer BC, Green J. The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis 1996;27:776-783
5. Yang Z, Yang Y, Zhao P, Chen K, Chen B, Lin Y, et al. A novel mutation in BBS7 gene causes Bardet-Biedl syndrome in a Chinese family. Mol Vis 2008;14:2304-2308
6. Kyttälä M, Tallila J, Salonen R, Kopra O, Kohlschmidt N, Paavola-Sakki P, et al. MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome. Nat Genet 2006;38:155-157
7. Leitch CC, Zaghloul NA, Davis EE, Stoetzel C, Diaz-Font A, Rix S, et al. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet 2008;40:443-448
8. Joy T, Cao H, Black G, Malik R, Charlton-Menys V, Hegele RA, et al. Alstrom syndrome (OMIM 203800): A case report and literature review. Orphanet J Rare Dis 2007;2:49.
9. Li G, Vega R, Nelms K, Gekakis N, Goodnow C, McNamara P, et al. A role for Alström syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 2007;3:e8.
10. Marshall JD, Beck S, Maffei P, Naggert JK. Alström syndrome. Eur J Hum Genet 2007;15:1193-1202
11. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 2005;165:675-683
12. Paisey RB, Hodge D, Williams K. Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome. J Hum Nutr Diet 2008;21:268-274
13. Sinha SK, Bhangoo A, Anhalt H, Maclaren N, Marshall JD, Collin GB, et al. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. J Pediatr Endocrinol Metab 2007;20:1045-1052
14. Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF. Alström syndrome: Report of 22 cases and literature review. Ophthalmology 1998;105:1274-1280
15. Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of Kearns-sayre syndrome: a complex mitochondrial encephalomyopathy. Pedriatr Endocrinol Rev 2007;4:117-137
16. Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 1992;37:97-103.
17. Isotani H, Fukumoto Y, Kawamura H, Furukawa K, Ohsawa N, Goto Y, et al. Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. Clin Endocrinol 1996;45:637-641
18. Rheuban KS, Ayres NA, Sellers TD, DiMarco JP. Near-fatal Kearns-Sayre syndrome: A case report and review of clinical manifestations. Clin Pediatr 1983;22:822-825
19. d'Annunzio G, Minuto N, D'Amato E, de Toni T, Lombardo F, Pasquali L, et al. Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): Clinical and genetic study. Diabetes Care 2008;31:1743-1745
20. Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol 2002;12:84-88
21. Smith CJ, Crock PA, King BR, Meldrum CJ, Scott RJ. Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care 2004;27:2003-2009
22. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997;34:838-841
23. Arden GB. The absence of diabetic retinopathy in patients with retinitis pigmentosa: Implications for pathophysiology and possible treatment. Br J Ophthalmol 2001;85:366-370
24. Paisey RB, Paisey RM, Thomson MP, Bower L, Maffei P, Shield JP, et al. Protection from clinical peripheral sensory neuropathy in Alstrom syndrome in contrast to early onset type2 diabetes. Diabetes Care 2009;32:462-464